Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Payables (2016 - 2021)

Historic Payables for ENDRA Life Sciences (NDRA) over the last 6 years, with Q3 2021 value amounting to $1.4 million.

  • ENDRA Life Sciences' Payables rose 936.79% to $1.4 million in Q3 2021 from the same period last year, while for Sep 2021 it was $1.4 million, marking a year-over-year increase of 936.79%. This contributed to the annual value of $910183.0 for FY2020, which is 5464.04% down from last year.
  • As of Q3 2021, ENDRA Life Sciences' Payables stood at $1.4 million, which was up 936.79% from $1.5 million recorded in Q2 2021.
  • ENDRA Life Sciences' 5-year Payables high stood at $2.0 million for Q4 2019, and its period low was $162302.0 during Q2 2017.
  • For the 5-year period, ENDRA Life Sciences' Payables averaged around $1.1 million, with its median value being $1.1 million (2018).
  • As far as peak fluctuations go, ENDRA Life Sciences' Payables surged by 36294.93% in 2018, and later crashed by 5464.04% in 2020.
  • Quarter analysis of 5 years shows ENDRA Life Sciences' Payables stood at $848214.0 in 2017, then rose by 14.9% to $974583.0 in 2018, then skyrocketed by 105.89% to $2.0 million in 2019, then plummeted by 54.64% to $910183.0 in 2020, then skyrocketed by 59.21% to $1.4 million in 2021.
  • Its Payables was $1.4 million in Q3 2021, compared to $1.5 million in Q2 2021 and $686650.0 in Q1 2021.